Haleon Strengthens Control Of China JV, Agrees Option To Buy
Joint venture business which markets Haleon's OTC drug brands in China will soon be 88% owned by the UK-based firm.

Joint venture business which markets Haleon's OTC drug brands in China will soon be 88% owned by the UK-based firm.